^
TMB-L
Mast Cell Leukemia
T-lymphocyte cell therapy
Sensitive: C3 – Early Trials
LDH-L
Mast Cell Leukemia
T-lymphocyte cell therapy
Sensitive: C3 – Early Trials
KIT D816V
Mast Cell Leukemia
abemaciclib
Sensitive: D – Preclinical
KIT D816V
Mast Cell Leukemia
palbociclib
Sensitive: D – Preclinical
KIT D816V
Mast Cell Leukemia
ribociclib
Sensitive: D – Preclinical